What Researchers Did
Researchers conducted a randomized controlled trial to evaluate the effect of two weeks of topical hyperbaric oxygen on diabetic foot ulcers in 28 patients.
What They Found
Both the topical hyperbaric oxygen group (12 patients) and the control group (16 patients) showed significant reductions in ulcer area and depth over 14 days. However, there was no statistically significant difference in ulcer size changes or microbial counts between the two treatment groups.
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers may not benefit from topical hyperbaric oxygen therapy as a primary treatment based on these findings. Standard wound care approaches appear to be similarly effective for ulcer size reduction.
Canadian Relevance
This study was not conducted in Canada and has no direct Canadian connection.
Study Limitations
The study's small sample size of 28 patients and short two-week treatment duration limit the generalizability of its findings.